Natera Inc. Common Stock vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $201.36 (market cap $37.63B). The key difference: Natera Inc. Common Stock is the larger of the two by market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 111 Days on average.
| NTRA | TTWO | |
|---|---|---|
Market Cap | $57.03B | $37.63B |
Volume | 1,131,157 | 2,610,144 |
Sector | Health | Technology |
52-Week High | $425.64 | $262.29 |
52-Week Low | $179.42 | $189.69 |
Typical Hold Time | 0 Days | 111 Days |
Enterprise Value | $56.18B | $38.74B |
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Take-Two Interactive (TTWO) trades at $200.32, down 4.07% on the day, with technical indicators showing a neutral to bearish short-term bias. The company faces fundamental challenges with a net loss of $4.48 billion in 2025 and negative profit margins, though revenue grew to $5.63 billion. Analyst sentiment remains strongly bullish with a 79% buy rating and $292.30 price target, supported by anticipation for Grand Theft Auto VI's November 2026 launch.
While near-term fundamentals show significant losses, the long-term investment thesis hinges on GTA VI's successful execution. Key risks include execution missteps, competitive pressures, and the company's high debt load. The substantial gap between current price and analyst targets presents potential upside if the company can return to profitability post-launch.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →